Canadian Psychiatric Association Research Articles

Experiences with large scale interhospital cooperative research in chemotherapy.

Back to table of contents Previous article Next article ArticleNo AccessEXPERIENCES WITH LARGE SCALE INTERHOSPITAL COOPERATIVE RESEARCH IN CHEMOTHERAPYEUGENE M. CAFFEY JR.EUGENE M. CAFFEY JR.Search for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.117.8.713AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail PDFThis content is only available as a PDF. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byCNS Drugs, Vol. 22, No. 6General Hospital Psychiatry, Vol. 22, No. 4Acta Psychiatrica Scandinavica, Vol. 100, No. 1Drug Development Research, Vol. 41, No. 1International Journal of Eating Disorders, Vol. 15, No. 3Pharmacology Biochemistry and Behavior, Vol. 27, No. 3Progress in Neuro-Psychopharmacology, Vol. 4, No. 6Life Sciences, Vol. 21, No. 12American Journal of Orthopsychiatry, Vol. 47, No. 3Journal of Psychiatric Research, Vol. 12, No. 1Journal of Autism and Childhood Schizophrenia, Vol. 2, No. 1Journal of Pharmaceutical Sciences, Vol. 59, No. 6Psychosomatics, Vol. 11, No. 6Total Fasting in Psychiatric Subjects: Psychological, Physiological and Biochemical Changes26 April 2017 | Canadian Psychiatric Association Journal, Vol. 12, No. 6BIBLIOGRAPHYPhenothiazine Bibliographies Volume 117Issue 8 February 1961Pages 713-719 Metrics PDF download History Published online 1 April 2006 Published in print 1 February 1961

The effect of R-1625 (Haloperidol) in mental syndromes: a multiblind study.

Back to table of contents Previous article Next article ArticleNo AccessTHE EFFECT OF R-1625 (HALOPERIDOL) IN MENTAL SYNDROMES: A MULTIBLIND STUDYH. AZIMA, H. DUROST, and DOROTHY ARTHURSH. AZIMASearch for more papers by this author, H. DUROSTSearch for more papers by this author, and DOROTHY ARTHURSSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.117.6.546AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "THE EFFECT OF R-1625 (HALOPERIDOL) IN MENTAL SYNDROMES: A MULTIBLIND STUDY." American Journal of Psychiatry, 117(6), pp. 546–547 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByCochrane Database of Systematic ReviewsCochrane Database of Systematic ReviewsCochrane Database of Systematic ReviewsHaloperidol och metylperidol12 July 2009 | Nordisk Psykiatrisk Tidsskrift, Vol. 22, No. 3CLINICAL EVALUATION OF NEUROLEPTIC DRUG ACTION, PARTICULARY CONSIDERING BUTYROPHENONES.Acta Psychiatrica Scandinavica, Vol. 41, No. S191The butyrophenones in the treatment of the psychotic patientComprehensive Psychiatry, Vol. 5, No. 3Acta Psychiatrica Scandinavica, Vol. 40, No. 1PsychopharmakotherapieThe Effects of Chlordiazepoxide (Librium) in Anxiety States: A Multi-Blind Study26 April 2017 | Canadian Psychiatric Association Journal, Vol. 7, No. 1Journal of Mental Science, Vol. 108, No. 452A CONTROLLED STUDY OF HALOPERIDOL: THE EFFECTS OF SMALL DOSAGESARTHUR S. SAMUELS1 April 2006 | American Journal of Psychiatry, Vol. 118, No. 3CLINICAL TRIAL WITH CYCLOPENTIMINEL. SCHWARZ, T. BAN, and R. SMITH1 April 2006 | American Journal of Psychiatry, Vol. 118, No. 3THE EFFECT OF AMPHENIDONE (DORNWAL) IN ANXIETY STATES: A MULTI-BLIND STUDYH. AZIMA, DOROTHY ARTHURS, and A. SILVER1 April 2006 | American Journal of Psychiatry, Vol. 118, No. 2A CLINICAL EVALUATION OF FOUR ANTIDEPRESSANT DRUGS(Nardil, Tofranil, Marplan, and Deprol)PAUL C. AGNEW, IRVING D. BARAN, HOWARD J. KLAPMAN, F. THEODORE REIDJR., JERRY J. STERN, and ROGER H. SLUTSKE1 April 2006 | American Journal of Psychiatry, Vol. 118, No. 2 Volume 117Issue 6 December 1960Pages 546-547 Metrics PDF download History Published online 1 April 2006 Published in print 1 December 1960

Further studies of the doctor as a crucial variable in the outcome of treatment with schizophrenic patients.

Further studies of the doctor as a crucial variable in the outcome of treatment with schizophrenic patients.

Persistent muscular restlessness after phenothiazine treatment: report of 3 cases.

Back to table of contents Previous article Next article ArticleNo AccessPERSISTENT MUSCULAR RESTLESSNESS AFTER PHENOTHIAZINE TREATMENT: REPORT OF 3 CASESWALTER KRUSEWALTER KRUSESearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.117.2.152AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "PERSISTENT MUSCULAR RESTLESSNESS AFTER PHENOTHIAZINE TREATMENT: REPORT OF 3 CASES." American Journal of Psychiatry, 117(2), pp. 152–153 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByExpanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment toolParkinsonism & Related Disorders, Vol. 77A unifying theory for the pathoetiologic mechanism of tardive dyskinesiaMedical Hypotheses, Vol. 140The Assessment and Treatment of Antipsychotic-Induced Akathisia23 April 2018 | The Canadian Journal of Psychiatry, Vol. 63, No. 11Journal of the Neurological Sciences, Vol. 389Tardive Dyskinesias24 February 2012Current Treatment Options in Neurology, Vol. 13, No. 3, Vol. 100, Vol. 95Acta Medica Scandinavica, Vol. 170, No. 6Drug-Induced Movement Disorders30 June 2016 | Journal of Pharmacy Practice, Vol. 20, No. 6The Consultant Pharmacist, Vol. 22, No. 2Tardive dyskinesia in geriatric patientsAging Health, Vol. 2, No. 5The Consultant Pharmacist, Vol. 21, No. 1Movement Disorders, Vol. 9, No. 2, Vol. 20045530The Barnes Akathisia Rating Scale–Revisited2 July 2016 | Journal of Psychopharmacology, Vol. 17, No. 4Comprehensive Psychiatry, Vol. 37, No. 2Biological Psychiatry, Vol. 31, No. 4Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy1 April 2006 | American Journal of Psychiatry, Vol. 147, No. 4Biological Psychiatry, Vol. 27, No. 4International Review of Psychiatry, Vol. 2, No. 3-4Movement Disorders, Vol. 4, No. 2Psychiatric Clinics of North America, Vol. 9, No. 1Sustained improvement in tardive dyskinesia with diazepam: Indirect evidence for corticolimbic involvementBrain Research Bulletin, Vol. 11, No. 2Annals of Neurology, Vol. 13, No. 4Treatment of tardive dyskinesia with diazepam: Indirect evidence for the involvement of limbic, possibly GABA-ergic mechanismsBrain Research Bulletin, Vol. 5Acta Psychiatrica Scandinavica, Vol. 46, No. 1Tardive Dyskinesia in Patients Treated with Major Neuroleptics: A Review of the LiteratureGEORGE E. CRANE1 April 2006 | American Journal of Psychiatry, Vol. 124, No. 8SOn the Rarity of "Irreversible" Oral Dyskinesias Following PhenothiazinesNATHAN S. KLINE1 April 2006 | American Journal of Psychiatry, Vol. 124, No. 8SPhenothiazine BibliographiesJournal of the American Geriatrics Society, Vol. 15, No. 6Acta Psychiatrica Scandinavica, Vol. 43, No. 3Archiv f�r Psychiatrie und Nervenkrankheiten Vereinigt mit Zeitschrift f�r die Gesamte Neurologie und Psychiatrie, Vol. 208, No. 4A Controlled Study of the Use of Thioridazine in the Treatment of Hyperactive and Aggressive Children in a Children's Psychiatric Hospital26 April 2017 | Canadian Psychiatric Association Journal, Vol. 9, No. 3Acta Psychiatrica Scandinavica, Vol. 40, No. 1Acta Psychiatrica Scandinavica, Vol. 40, No. 1 Volume 117Issue 2 August 1960Pages 152-153 Metrics PDF download History Published online 1 April 2006 Published in print 1 August 1960

Report of the Committee on Economics—C.P.A

The following report was presented to and adopted by the Board of Directors of the Canadian Psychiatric Association at a meeting in March 1960 in Toronto. They direct that it be published for the information of all members.

Thioridazine (mellaril) in the treatment of chronic schizophrenics.

Back to table of contents Previous article Next article ArticleNo AccessTHIORIDAZINE (MELLARIL)IN THE TREATMENT OF CHRONIC SCHIZOPHRENICSJOSEPH A. BARSA, and JOHN C. SAUNDERSJOSEPH A. BARSASearch for more papers by this author, and JOHN C. SAUNDERSSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.116.11.1028AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "THIORIDAZINE (MELLARIL)IN THE TREATMENT OF CHRONIC SCHIZOPHRENICS." American Journal of Psychiatry, 116(11), pp. 1028–1029 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited By2-Substituted and 1,2-Disubstituted PiperidinesContact Dermatitis, Vol. 17, No. 4Contact Dermatitis, Vol. 2, No. 3Phenothiazine BibliographiesA Controlled Study of the Use of Thioridazine in the Treatment of Hyperactive and Aggressive Children in a Children's Psychiatric Hospital26 April 2017 | Canadian Psychiatric Association Journal, Vol. 9, No. 3 Volume 116Issue 11 May 1960Pages 1028-1029 Metrics PDF download History Published online 1 April 2006 Published in print 1 May 1960

Canadian Psychiatric Association Annual General Meeting — 1960

Canadian Psychiatric Association Annual General Meeting — 1960

Discontinuation of treatment with ataractic drugs. A preliminary report.

Back to table of contents Previous article Next article ArticleNo AccessDISCONTINUATION OF TREATMENT WITH ATARACTIC DRUGSA Preliminary ReportMARTIN GROSS, IRENE L. HITCHMAN, WALTER P. REEVES, JORDAN LAWRENCE, and PAULINE C. NEWELLMARTIN GROSSSearch for more papers by this author, IRENE L. HITCHMANSearch for more papers by this author, WALTER P. REEVESSearch for more papers by this author, JORDAN LAWRENCESearch for more papers by this author, and PAULINE C. NEWELLSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.116.10.931AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "DISCONTINUATION OF TREATMENT WITH ATARACTIC DRUGS ." American Journal of Psychiatry, 116(10), pp. 931–932 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByA historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoiseSchizophrenia Research, Vol. 229Maintenance treatment with antipsychotic drugs for schizophrenia11 August 2020 | Cochrane Database of Systematic Reviews, Vol. 2020, No. 8CNS Drugs, Vol. 29, No. 8Cochrane Database of Systematic ReviewsCochrane Database of Systematic Reviews, Vol. 1 / 2Aspects of Long-Term Treatment with Neuroleptics Historical and Literature Review—Personal Experience with Fluspirilene and Penfluridol25 June 2016 | Journal of International Medical Research, Vol. 3, No. 2ÉTude Comparative De L'énanthate De Fluphénazine, Du Bichlorhydrate De Fluphénazine Et Du Placebo Chez Le Schizophrène Chronique26 April 2017 | Canadian Psychiatric Association Journal, Vol. 14, No. 2Psychopharmacologia, Vol. 14, No. 4Further Studies with Fluphenazine Enanthate: II. Relapse Rate in Patients Deprived of MedicationC. L. RAVARIS, L. A. WEAVER, and G. W. BROOKS1 April 2006 | American Journal of Psychiatry, Vol. 124, No. 2Phenothiazine BibliographiesBritish Journal of Psychiatry, Vol. 112, No. 484British Journal of Psychiatry, Vol. 111, No. 471Value of Continuous Drug Administration for Chronic Long-Term Mental Hospital Patients26 April 2017 | Canadian Psychiatric Association Journal, Vol. 9, No. 4DRUG MAINTENANCE PROBLEMS OF REHABILITATED MENTAL PATIENTS: THE CURRENT DRUG DOSAGE "MERRY-GO-ROUND"FRED M. FORREST, CLYDE W. GEITER, HAROLD L. SNOW, and MEYER STEINBACH1 April 2006 | American Journal of Psychiatry, Vol. 121, No. 1A QUANTITATIVE STUDY OF CHLORPROMAZINE AND ITS SULFOXIDES IN THE URINE OF PSYCHOTIC PATIENTSCHIEN LI HUANG, and ALBERT A. KURLAND1 April 2006 | American Journal of Psychiatry, Vol. 118, No. 5 Volume 116Issue 10 April 1960Pages 931-932 Metrics PDF download History Published online 1 April 2006 Published in print 1 April 1960

CHILDREN AND ADOLESCENTS WHO HAVE KILLED

CHILDREN AND ADOLESCENTS WHO HAVE KILLED

Pavlovian contemporary psychiatry in the USSR

Back to table of contents Previous article Next article ArticleNo AccessPAVLOVIAN CONTEMPORARY PSYCHIATRY IN THE USSRKONSTANTIN M. BYKOVKONSTANTIN M. BYKOVSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.116.3.203AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail PDFThis content is only available as a PDF. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByPavlov as a psychologistThe Pavlovian Journal of Biological Science, Vol. 22, No. 3BIBLIOGRAPHYQuelques Aspects Theoriques De La Psychiatrie En Russie Et Autres Pays De L'Europe De L'est3 May 2017 | Canadian Psychiatric Association Journal, Vol. 6, No. 2 Volume 116Issue 3 September 1959Pages 203-207 Metrics PDF download History Published online 1 April 2006 Published in print 1 September 1959

Physiology of the mammary glands.

ArticlesPhysiology of the Mammary GlandsJ. L. LinzellJ. L. LinzellPublished Online:01 Jul 1959https://doi.org/10.1152/physrev.1959.39.3.534MoreSectionsPDF (7 MB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat Previous Back to Top Next Download PDF FiguresReferencesRelatedInformation Cited ByEstrogen increases calcitonin gene-related peptide-immunoreactive sensory innervation of rat mammary gland1 January 2004 | Journal of Neurobiology, Vol. 59, No. 2Differential Recruitment of T- and IgA B-lymphocytes in the Developing Mammary Gland in Relation to Homing Receptors and Vascular Addressins26 June 2016 | Journal of Histochemistry & Cytochemistry, Vol. 47, No. 12Udder characteristics in Toggenburg dairy goatsSmall Ruminant Research, Vol. 2, No. 2The effects of neonatal capsaicin treatment on the sensory innervation of the nipple and on the milk ejection reflex in the ratExperimental Brain Research, Vol. 73, No. 1Ultrasonic doppler study of the hormonal response of blood flow in the normal human breastUltrasound in Medicine & Biology, Vol. 13, No. 3Afferent projections from the mammary glands to the spinal cord in the lactating rat—II. Electrophysiological responses of spinal neurons during stimulation of the nipples, including sucklingNeuroscience, Vol. 19, No. 2Milk yield and composition in mice: Effects of litter size and lactation numberComparative Biochemistry and Physiology Part A: Physiology, Vol. 84, No. 1Drip breast milk: its composition, collection and pasteurizationEarly Human Development, Vol. 1, No. 3Some Neglected Aspects of the Anatomy of Human BreastsJournal of Investigative Dermatology, Vol. 63, No. 1The Mammary Glands of Rhesus MonkeysJournal of Investigative Dermatology, Vol. 63, No. 1Trifluperidol-Induged Lactation26 April 2017 | Canadian Psychiatric Association Journal, Vol. 19, No. 1A simple technique for measuring the rate of milk secretion in the ratComparative Biochemistry and Physiology Part A: Physiology, Vol. 43, No. 2Enzyme activities and electronmicroscopic structure of rat milk fractions obtained after centrifugationZeitschrift f�r Zellforschung und mikroskopische Anatomie, Vol. 131, No. 2Rate of growth and intake of milk in a suckling echidnaComparative Biochemistry and Physiology, Vol. 16, No. 4The effects of weaning and milk on mammary fatty acid synthesisBiochimica et Biophysica Acta (BBA) - Specialized Section on Lipids and Related Subjects, Vol. 84, No. 3INHIBITION OF LACTOGENESIS BY COMBINED ORAL PROGESTOGENS AND ŒSTROGENSThe Lancet, Vol. 282, No. 7303 More from this issue > Volume 39Issue 3July 1959Pages 534-576 https://doi.org/10.1152/physrev.1959.39.3.534PubMed13674904History Published online 1 July 1959 Published in print 1 July 1959 Metrics

Catatonic-like states following phenothiazine therapy.

Back to table of contents Previous article Next article ArticleNo AccessCATATONIC-LIKE STATES FOLLOWING PHENOTHIAZINE THERAPYRUPERT H. MAYRUPERT H. MAYSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.115.12.1119AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "CATATONIC-LIKE STATES FOLLOWING PHENOTHIAZINE THERAPY." American Journal of Psychiatry, 115(12), pp. 1119–1120 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByTherapy of Catatonia in Schizophrenia and Schizophrenia Spectrum Disorders29 September 2022 | Psikhiatriya, Vol. 20, No. 3Neuroleptic-Induced CatatoniaJournal of Clinical Psychopharmacology, Vol. 30, No. 1Journal of Intellectual Disability Research, Vol. 29, No. 3Schizophrenia Research, Vol. 27, No. 1Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 14, No. 1Journal of Neurology, Neurosurgery & Psychiatry, Vol. 49, No. 9Neuroleptic Malignant Syndrome: Detection and ManagementPsychiatric Annals, Vol. 15, No. 12British Journal of Psychiatry, Vol. 147, No. 3British Journal of Psychiatry, Vol. 142, No. 1Psychosomatics, Vol. 23, No. 9Psychosomatics, Vol. 23, No. 3Psychotic Exacerbation with Haloperidol30 August 2016 | Drug Intelligence & Clinical Pharmacy, Vol. 15, No. 3The catatonic dilemma1 April 2006 | American Journal of Psychiatry, Vol. 135, No. 10CNS EFFECTS OF NEUROLEPTIC AGENTSPsychiatric Annals, Vol. 5, No. 11British Journal of Psychiatry, Vol. 121, No. 563HYSTERIA AND DRUG-INDUCED DYSTONIAActa Psychiatrica Scandinavica, Vol. 45, No. S212Prochlorperazine — A Review of the Literature since 1956 *26 April 2017 | Canadian Psychiatric Association Journal, Vol. 14, No. 3An Unusual Neurological Side Effect of Psychotropic Drug Treatment26 April 2017 | Canadian Psychiatric Association Journal, Vol. 13, No. 6Phenothiazine BibliographiesPHENOTHIAZINE-INDUCED ACUTE PSYCHOTIC REACTION: THE "PSYCHOTOXICITY" OF A DRUGDANIEL S. CHAFFIN1 April 2006 | American Journal of Psychiatry, Vol. 121, No. 1ACUTE TOXIC PSYCHOSIS CONCURRENT WITH PHENOTHIAZINE THERAPYALBERT W. LANG, and ROBERT A. MOORE1 April 2006 | American Journal of Psychiatry, Vol. 117, No. 10New England Journal of Medicine, Vol. 264, No. 6Arquivos de Neuro-Psiquiatria, Vol. 19, No. 1Psychosomatics, Vol. 1, No. 3 Volume 115Issue 12 June 1959Pages 1119-1120 Metrics PDF download History Published online 1 April 2006 Published in print 1 June 1959

Post-encephalitic behavior disorder; a forgotten entity: a report of 100 cases.

Back to table of contents Previous article Next article ArticleNo AccessPOST-ENCEPHALITIC BEHAVIOR DISORDER—A FORGOTTEN ENTITY: A REPORT OF 100 CASESSOL LEVYSOL LEVYSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.115.12.1062AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail PDFThis content is only available as a PDF. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byFunctional Neurologic Disorders, disorders to be managed by neurologists, or are neurologists wandering in a dangerous field with inadequate resources?17 March 2023 | Frontiers in Psychiatry, Vol. 14A case of Sars-Cov-2-related mania with prominent psychosis>Psychiatry Research, Vol. 306REAd. Revista Eletrônica de Administração (Porto Alegre), Vol. 21, No. 1ADHD Attention Deficit and Hyperactivity Disorders, Vol. 6, No. 3Acta Psychiatrica Scandinavica, Vol. 125, No. 1Determinismo biológico e as neurociências no caso do transtorno de déficit de atenção com hiperatividadePhysis: Revista de Saúde Coletiva, Vol. 22, No. 3Developmental Medicine & Child Neurology, Vol. 10, No. 3Journal of the History of the Behavioral Sciences, Vol. 42, No. 4Journal of the History of the Behavioral Sciences, Vol. 36, No. 2Topical Review: La Crosse and Other Forms of California Encephalitis2 July 2016 | Journal of Child Neurology, Vol. 14, No. 1Acta Psychiatrica Scandinavica, Vol. 85, No. s368Journal of Child Psychology and Psychiatry, Vol. 18, No. 2Adaptive and Learning Skills in Juvenile Delinquents19 August 2016 | Journal of Learning Disabilities, Vol. 9, No. 9American Journal of Orthopsychiatry, Vol. 42, No. 3Hyperkinesia Delineation of Two Patterns24 July 2016 | Exceptional Children, Vol. 38, No. 5Effects of Amphetamine Therapy and Prescriptive Tutoring on the Behavior and Achievement of Lower Class Hyperactive Children18 August 2016 | Journal of Learning Disabilities, Vol. 4, No. 9Proceedings of the Royal Society of Medicine, Vol. 62, No. 1Journal of the American Academy of Child Psychiatry, Vol. 5, No. 3Hyperactivity in Twins26 April 2017 | Canadian Psychiatric Association Journal, Vol. 10, No. 5Studies on the Hyperactive Child I: Some Preliminary Findings26 April 2017 | Canadian Psychiatric Association Journal, Vol. 9, No. 2The “Brain-Injured” Child in a Clinic Population: A Statistical Description24 July 2016 | Exceptional Children, Vol. 30, No. 6American Journal of Orthopsychiatry, Vol. 32, No. 3 Volume 115Issue 12 June 1959Pages 1062-1067 Metrics PDF download History Published online 1 April 2006 Published in print 1 June 1959

Comparison of proclorperazine and chlorpromazine in hospitalized chronic schizophrenics.

Back to table of contents Previous article Next article ArticleNo AccessCOMPARISON OF PROCLORPERAZINE AND CHLORPROMAZINE IN HOSPITALIZED CHRONIC SCHIZOPHRENICSPETER D. KING, and WALTER WEINBERGERPETER D. KINGSearch for more papers by this author, and WALTER WEINBERGERSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.115.11.1026AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "COMPARISON OF PROCLORPERAZINE AND CHLORPROMAZINE IN HOSPITALIZED CHRONIC SCHIZOPHRENICS." American Journal of Psychiatry, 115(11), pp. 1026–1027 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByCochrane Database of Systematic ReviewsProchlorperazine — A Review of the Literature since 1956 *26 April 2017 | Canadian Psychiatric Association Journal, Vol. 14, No. 3Phenothiazine BibliographiesDISCUSSION AND STUDY OF VERTEBRAL FRACTURES IN ELECTROCONVULSIVE THERAPYPETER D. KING1 April 2006 | American Journal of Psychiatry, Vol. 119, No. 3INDOKLON SYMPOSIUM IN NEW ORLEANS, MARCH 1962B. E. MCLAUGHLIN1 April 2006 | American Journal of Psychiatry, Vol. 119, No. 3Journal of the American Geriatrics Society, Vol. 9, No. 4Journal of Mental Science, Vol. 107, No. 448Arquivos de Neuro-Psiquiatria, Vol. 19, No. 1 Volume 115Issue 11 May 1959Pages 1026-1027 Metrics PDF download History Published online 1 April 2006 Published in print 1 May 1959

Withdrawal from neuroleptic drugs.

There have been few reports in the literature of the effects of sudden withdrawal of the drugs more commonly used in the treatment of severe mental disorders. For this reason, it is felt that the occurrence of a definite clinical syndrome following their withdrawal should be reported. The patients in this study were a hardcore group of 28 severely and chronically disturbed schizophrenic women who had responded to a wide variety of drug regimens by only moderate quieting. They ranged in age from 19 to 53, with a mean of 40.4. Their length of continuous hospitalization ranged from 1 to 25 years, with a mean of 11.7. The subjects had been receiving chlorpromazine, reserpine, or a combination of the two for periods ranging from 18 months to 44 months with the exception of one case whose medication had been intermittently administered over a period of 17 months. The average duration of drug treatment prior to our study in these 28 cases was about 35 months. The doses which the pati nts were receiving at the time of the study ranged from 150 to 600 mgs. of chiorpromazine or 1.5 to 4 mgs. of reserpine or, in combination, 150 mgs. of chiorpromazine with 3 mgs. of reserpine. Most patients were receiving trihexiphenidyl, procycidine hydrochloride, or benztropine methanesulfonate for the relief of extrapyramidal dysfunction. The patients were to receive a new medication in an attempt to evaluate its effectiveness for therapy in this group. Because of previous experiences with withdrawal phenomena in scattered cases, we felt it would be wise for them to be free of their previous medication for at least 2 or 3 weeks. Accordingly, we abruptly substituted a placebo for their usual medication. The first day after the change to the placebo, the patients on the ward seemed

Proclorperazine in the treatment of the schizophrenias.

Back to table of contents Previous article Next article ArticleNo AccessPROCLORPERAZINE IN THE TREATMENT OF THE SCHIZOPHRENIASVERONICA M. PENNINGTONVERONICA M. PENNINGTONSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.115.9.820AboutSectionsView articleAbstractPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleAbstractProclorperazine, because of its behavioral potency, lack of serious side effects, and small dosage, is an effective psychochemical. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByProchlorperazine — A Review of the Literature since 1956 *26 April 2017 | Canadian Psychiatric Association Journal, Vol. 14, No. 3Phenothiazine BibliographiesArquivos de Neuro-Psiquiatria, Vol. 19, No. 1 Volume 115Issue 9 March 1959Pages 820-821 Metrics PDF download History Published online 1 April 2006 Published in print 1 March 1959

Objects and By-Laws of the Canadian Psychiatric Association—Revised 1958

Objects and By-Laws of the Canadian Psychiatric Association—Revised 1958

The fear of becoming insane.

Back to table of contents Previous article Next article ArticlesNo AccessThe Fear of Becoming InsaneHenry G. Grand, M.D.Henry G. GrandNew York, N. Y.Search for more papers by this author, M.D.Published Online:30 Apr 2018https://doi.org/10.1176/appi.psychotherapy.1959.13.1.51AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail PDFThis content is only available as a PDF. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - APT - American Journal of Psychotherapy $35.00 Add to cart PPV Articles - APT - American Journal of Psychotherapy Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byThe Trauma of Being Psychotic: A Neglected Element in the Management of Chronic Schizophrenia?26 April 2017 | Canadian Psychiatric Association Journal, Vol. 22, No. 5 Volume 13Issue 1 1959, pp. 1–263Pages 51-54 Metrics PDF download History Published online 30 April 2018 Published in print 1 January 1959

Is adrenochrome present in the blood.

Back to table of contents Previous article Next article ArticleNo AccessIS ADRENOCHROME PRESENT IN THE BLOOD?STEPHEN SZARA, JULIUS AXELROD, and SEYMOUR PERLINSTEPHEN SZARASearch for more papers by this author, JULIUS AXELRODSearch for more papers by this author, and SEYMOUR PERLINSearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.115.2.162AboutSectionsView articleAbstractPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleAbstract1. A specific and sensitive method for the estimation of adrenochrome in plasma is described.2. Adrenochrome could not be detected in the plasma of normal and schizophrenic subjects. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByActa Pharmacologica et Toxicologica, Vol. 19, No. S1Annals of the New York Academy of Sciences, Vol. 80, No. 3Neurotoxicity Research, Vol. 4, No. 2, Vol. 65Yesterday, Today and Tomorrow a Point of View26 April 2017 | Canadian Psychiatric Association Journal, Vol. 18, No. 5, Vol. 6Biochemical Pharmacology, Vol. 17, No. 7Comprehensive Psychiatry, Vol. 9, No. 2Nature, Vol. 217, No. 5130Biochemical Basis of Mental DiseaseArchives Internationales de Physiologie et de Biochimie, Vol. 75, No. 4REFERENCESActa Psychiatrica Scandinavica, Vol. 41, No. S189Archiv für Kreislaufforschung, Vol. 49, No. 1-2Ergebnisse der Physiologie Biologischen Chemie und Experimentellen Pharmakologie, Vol. 58, No. 1, Vol. 58Schizophernia: A Critique of Recent Genetic-biochemical FormulationsNature, Vol. 206, No. 4989Canadian Anaesthetists’ Society Journal, Vol. 12, No. 2, Vol. 5Archives of Biochemistry and Biophysics, Vol. 101, No. 1Journal of Psychiatric Research, Vol. 1, No. 1PERSISTENT MUSCULAR RESTLESSNESS AFTER PHENOTHIAZINE TREATMENT: REPORT OF 3 CASESWALTER KRUSE1 April 2006 | American Journal of Psychiatry, Vol. 117, No. 2ON THE MEASUREMENT OF ADRENOCHROME IN BLOODAXEL RANDRUP, and IB MUNKVAD1 April 2006 | American Journal of Psychiatry, Vol. 117, No. 2THE PRESENCE OF ADRENOCHROME IN BLOODEditor, The American Journal of Psychiatry:A. Hoffer, and A. N. Payza1 April 2006 | American Journal of Psychiatry, Vol. 116, No. 7REPLY TO THE FOREGOINGEditor, The American Journal of Psychiatry:Stephen Szara, and Julius Axelrod1 April 2006 | American Journal of Psychiatry, Vol. 116, No. 7DR. KARPMAN'S BOOK : THE HANGOVEREditor, The American Journal of Psychiatry:Benjamin Karpman1 April 2006 | American Journal of Psychiatry, Vol. 116, No. 7REPLY TO THE FOREGOINGEditor, The American Journal of Psychiatry:Stephen Fleck1 April 2006 | American Journal of Psychiatry, Vol. 116, No. 7The Lancet, Vol. 275, No. 7137Nordisk Psykiatrisk Tidsskrift, Vol. 14, No. 1ON THE RELATIONSHIP OF ADRENALINE AND ITS OXIDATION PRODUCTS TO SCHIZOPHRENIAAARON FELDSTEIN1 April 2006 | American Journal of Psychiatry, Vol. 116, No. 5A NOTE ON THE CLINICAL EFFECTS OF PERPHENAZINE AT VERY HIGH DOSAGESARTHUR N. LARSON, JOHN S. HAMLON, and LLOYD K. SINES1 April 2006 | American Journal of Psychiatry, Vol. 116, No. 5Biochemical Theories of SchizophreniaScience, Vol. 129, No. 3362Archiv f�r Psychiatrie und Nervenkrankheiten Vereinigt mit Zeitschrift f�r die Gesamte Neurologie und Psychiatrie, Vol. 198, No. 6Journal of Chronic Diseases, Vol. 8, No. 3 Volume 115Issue 2 August 1958Pages 162-163 Metrics PDF download History Published online 1 April 2006 Published in print 1 August 1958

Use of chlorpromazine combined with proclorperazine.

Back to table of contents Previous article Next article ArticleNo AccessUSE OF CHLORPROMAZINE COMBINED WITH PROCLORPERAZINEJOSEPH A. BARSAJOSEPH A. BARSASearch for more papers by this authorPublished Online:1 Apr 2006https://doi.org/10.1176/ajp.114.12.1112AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail "USE OF CHLORPROMAZINE COMBINED WITH PROCLORPERAZINE." American Journal of Psychiatry, 114(12), pp. 1112–1113 Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited ByProchlorperazine — A Review of the Literature since 1956 *26 April 2017 | Canadian Psychiatric Association Journal, Vol. 14, No. 3Phenothiazine BibliographiesPsychopharmakotherapieA COMPARATIVE STUDY OF ANTIDEPRESSANTS IN BALANCED THERAPYDAVID C. ENGLISH1 April 2006 | American Journal of Psychiatry, Vol. 117, No. 10Archiv f�r Psychiatrie und Nervenkrankheiten Vereinigt mit Zeitschrift f�r die Gesamte Neurologie und Psychiatrie, Vol. 198, No. 6Acta Psychiatrica Scandinavica, Vol. 34 Volume 114Issue 12 June 1958Pages 1112-1113 Metrics PDF download History Published online 1 April 2006 Published in print 1 June 1958